Citation Impact
Citing Papers
Discovery, mechanisms of action and combination therapy of artemisinin
2009 Standout
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
2008
Leishmaniasis
2018 Standout
Neglected tropical diseases
2009 Standout
Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis
2006
Chemistry and biology of monoterpene indole alkaloid biosynthesis
2006 Standout
Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
2011
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Análise dos registros de leishmaniose visceral pelo método de captura-recaptura
2007
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Natural products: An evolving role in future drug discovery
2011 Standout
Effectiveness of Antimalarial Drugs
2005
A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries
2016
Paromomycin
2008
The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination
2008 Standout
Cutaneous leishmaniasis
2007 Standout
Population movement: a key factor in the epidemiology of neglected tropical diseases
2010
Combination therapy for visceral leishmaniasis
2010
Schistosomiasis
2018 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis
2015
Injectable Paromomycin for Visceral Leishmaniasis in India
2007
Leishmaniasis Worldwide and Global Estimates of Its Incidence
2012 Standout
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Protein‐energy malnutrition as a risk factor for visceral leishmaniasis: a review
2009
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Unseen Kala‐azar deaths in south Sudan (1999–2002)
2006
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria
2009
Liposomal amphotericin B as a treatment for human leishmaniasis
2012
Treatment options for visceral leishmaniasis
2006
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
2019 Standout
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Causes and consequences of higher Leishmania infantum burden in patients with kala‐azar: a study of 625 patients
2017
Advances in leishmaniasis
2005 Standout
EVALUATION OF A NEW RECOMBINANT K39 RAPID DIAGNOSTIC TEST FOR SUDANESE VISCERAL LEISHMANIASIS
2006
Kala-azar Epidemiology and Control, Southern Sudan
2008
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
UTILITY OF LYMPH NODE ASPIRATION IN THE DIAGNOSIS OF VISCERAL LEISHMANIASIS IN SUDAN
2007
Antimony Toxicity
2010
Drug Resistance in Leishmaniasis
2006 Standout
Works of Kees Keus being referenced
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine–pyrimethamine and artesunate plus amodiaquine combinations
2005
Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, South Sudan
2003
Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern Sudan
2004
Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends
2010
Treatment of Kala-Azar in Southern Sudan using a 17-Day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-Day Sodium Stibogluconate Monotherapy
2007
SHORT REPORT: ASSOCIATION BETWEEN CHLOROQUINE AND AMODIAQUINE RESISTANCE AND ALLELIC VARIATION IN THE PLASMODIUM FALCIPARUM MULTIPLE DRUG RESISTANCE 1 GENE AND THE CHLOROQUINE RESISTANCE TRANSPORTER GENE IN ISOLATES FROM THE UPPER NILE IN SOUTHERN SUDAN
2003